Development of novel drug delivery systems for targeted cancer therapy

Thesis Abstract

Abstract
Cancer remains one of the leading causes of mortality worldwide, necessitating the continual advancement of treatment strategies to improve patient outcomes. In this context, the development of novel drug delivery systems for targeted cancer therapy has emerged as a promising approach to enhance the efficacy and reduce the systemic toxicity of anticancer agents. This thesis explores the design, development, and evaluation of innovative drug delivery systems tailored for specific targeting of cancer cells while sparing healthy tissues. The introduction section provides a comprehensive overview of the challenges associated with conventional cancer therapy, emphasizing the need for targeted drug delivery systems. The background of the study delves into the principles of targeted therapy and the rationale for developing novel drug delivery systems for cancer treatment. The problem statement highlights the limitations of current treatment modalities and the urgent need for more effective and less toxic approaches. The objectives of the study are outlined to guide the research process, focusing on the design and optimization of drug delivery systems for targeted cancer therapy. The limitations and scope of the study are also discussed to provide a clear understanding of the research boundaries. The significance of the study underscores the potential impact of developing targeted drug delivery systems in improving cancer treatment outcomes and enhancing patient quality of life. The literature review chapter critically examines existing research on drug delivery systems for cancer therapy, analyzing various approaches, including nanoparticles, liposomes, and micelles. The review identifies key challenges and recent advancements in the field, laying the foundation for the development of novel delivery platforms. The research methodology chapter details the experimental design, materials, and methods employed in the synthesis and characterization of targeted drug delivery systems. Various techniques, such as nanoparticle formulation, drug loading, and in vitro evaluation, are described to elucidate the research process. The discussion of findings chapter presents the results of the experimental studies, including drug release profiles, cellular uptake assays, and cytotoxicity assessments. The data analysis and interpretation provide insights into the performance and targeting efficiency of the developed drug delivery systems, highlighting their potential for clinical translation. In conclusion, this thesis summarizes the key findings and implications of the study, emphasizing the significance of targeted drug delivery systems in revolutionizing cancer therapy. The summary encapsulates the research journey, from conceptualization to experimentation, underscoring the innovative approaches and promising outcomes in the field of cancer drug delivery. Overall, this thesis contributes to the advancement of targeted cancer therapy by developing novel drug delivery systems that hold great promise for improving treatment outcomes and reducing the side effects associated with conventional chemotherapy. The research findings pave the way for further investigations and eventual clinical translation, offering new hope for cancer patients in their fight against this devastating disease.